nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Rash—Bortezomib—hematologic cancer	0.000379	0.000379	CcSEcCtD
Oritavancin—Dermatitis—Bortezomib—hematologic cancer	0.000379	0.000379	CcSEcCtD
Oritavancin—Infestation NOS—Methotrexate—hematologic cancer	0.000378	0.000378	CcSEcCtD
Oritavancin—Infestation—Methotrexate—hematologic cancer	0.000378	0.000378	CcSEcCtD
Oritavancin—Headache—Bortezomib—hematologic cancer	0.000377	0.000377	CcSEcCtD
Oritavancin—Rash—Bleomycin—hematologic cancer	0.000376	0.000376	CcSEcCtD
Oritavancin—Dermatitis—Bleomycin—hematologic cancer	0.000376	0.000376	CcSEcCtD
Oritavancin—Hypersensitivity—Ifosfamide—hematologic cancer	0.000376	0.000376	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	0.000375	0.000375	CcSEcCtD
Oritavancin—Vomiting—Vinorelbine—hematologic cancer	0.000373	0.000373	CcSEcCtD
Oritavancin—Angioedema—Dexamethasone—hematologic cancer	0.000371	0.000371	CcSEcCtD
Oritavancin—Angioedema—Betamethasone—hematologic cancer	0.000371	0.000371	CcSEcCtD
Oritavancin—Diarrhoea—Thalidomide—hematologic cancer	0.000371	0.000371	CcSEcCtD
Oritavancin—Dizziness—Thiotepa—hematologic cancer	0.000371	0.000371	CcSEcCtD
Oritavancin—Rash—Vinorelbine—hematologic cancer	0.00037	0.00037	CcSEcCtD
Oritavancin—Dermatitis—Vinorelbine—hematologic cancer	0.00037	0.00037	CcSEcCtD
Oritavancin—Headache—Vinorelbine—hematologic cancer	0.000368	0.000368	CcSEcCtD
Oritavancin—Immune system disorder—Prednisone—hematologic cancer	0.000367	0.000367	CcSEcCtD
Oritavancin—Hypersensitivity—Vincristine—hematologic cancer	0.000366	0.000366	CcSEcCtD
Oritavancin—Pruritus—Alitretinoin—hematologic cancer	0.000365	0.000365	CcSEcCtD
Oritavancin—Eosinophilia—Doxorubicin—hematologic cancer	0.000364	0.000364	CcSEcCtD
Oritavancin—Infection—Triamcinolone—hematologic cancer	0.000363	0.000363	CcSEcCtD
Oritavancin—Pruritus—Ifosfamide—hematologic cancer	0.000361	0.000361	CcSEcCtD
Oritavancin—Dizziness—Thalidomide—hematologic cancer	0.000359	0.000359	CcSEcCtD
Oritavancin—Nausea—Bortezomib—hematologic cancer	0.000357	0.000357	CcSEcCtD
Oritavancin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000357	0.000357	CcSEcCtD
Oritavancin—Hypersensitivity—Irinotecan—hematologic cancer	0.000357	0.000357	CcSEcCtD
Oritavancin—Tachycardia—Triamcinolone—hematologic cancer	0.000357	0.000357	CcSEcCtD
Oritavancin—Vomiting—Thiotepa—hematologic cancer	0.000356	0.000356	CcSEcCtD
Oritavancin—Diarrhoea—Carmustine—hematologic cancer	0.000356	0.000356	CcSEcCtD
Oritavancin—Nausea—Bleomycin—hematologic cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Infestation NOS—Epirubicin—hematologic cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Infestation—Epirubicin—hematologic cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Malnutrition—Prednisone—hematologic cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Rash—Thiotepa—hematologic cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Dermatitis—Thiotepa—hematologic cancer	0.000353	0.000353	CcSEcCtD
Oritavancin—Diarrhoea—Alitretinoin—hematologic cancer	0.000353	0.000353	CcSEcCtD
Oritavancin—Headache—Thiotepa—hematologic cancer	0.000351	0.000351	CcSEcCtD
Oritavancin—Diarrhoea—Ifosfamide—hematologic cancer	0.000349	0.000349	CcSEcCtD
Oritavancin—Nausea—Vinorelbine—hematologic cancer	0.000349	0.000349	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000348	0.000348	CcSEcCtD
Oritavancin—Myalgia—Betamethasone—hematologic cancer	0.000346	0.000346	CcSEcCtD
Oritavancin—Myalgia—Dexamethasone—hematologic cancer	0.000346	0.000346	CcSEcCtD
Oritavancin—Vomiting—Thalidomide—hematologic cancer	0.000345	0.000345	CcSEcCtD
Oritavancin—Dizziness—Carmustine—hematologic cancer	0.000344	0.000344	CcSEcCtD
Oritavancin—Rash—Thalidomide—hematologic cancer	0.000342	0.000342	CcSEcCtD
Oritavancin—Dermatitis—Thalidomide—hematologic cancer	0.000342	0.000342	CcSEcCtD
Oritavancin—Dizziness—Alitretinoin—hematologic cancer	0.000341	0.000341	CcSEcCtD
Oritavancin—Diarrhoea—Vincristine—hematologic cancer	0.00034	0.00034	CcSEcCtD
Oritavancin—Headache—Thalidomide—hematologic cancer	0.00034	0.00034	CcSEcCtD
Oritavancin—Dizziness—Ifosfamide—hematologic cancer	0.000337	0.000337	CcSEcCtD
Oritavancin—Pruritus—Gemcitabine—hematologic cancer	0.000334	0.000334	CcSEcCtD
Oritavancin—Nausea—Thiotepa—hematologic cancer	0.000333	0.000333	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000333	0.000333	CcSEcCtD
Oritavancin—Diarrhoea—Irinotecan—hematologic cancer	0.000331	0.000331	CcSEcCtD
Oritavancin—Diarrhoea—Mitoxantrone—hematologic cancer	0.000331	0.000331	CcSEcCtD
Oritavancin—Vomiting—Carmustine—hematologic cancer	0.000331	0.000331	CcSEcCtD
Oritavancin—Infection—Betamethasone—hematologic cancer	0.000329	0.000329	CcSEcCtD
Oritavancin—Infection—Dexamethasone—hematologic cancer	0.000329	0.000329	CcSEcCtD
Oritavancin—Dizziness—Vincristine—hematologic cancer	0.000329	0.000329	CcSEcCtD
Oritavancin—Rash—Carmustine—hematologic cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Dermatitis—Carmustine—hematologic cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Vomiting—Alitretinoin—hematologic cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Infestation NOS—Doxorubicin—hematologic cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Infestation—Doxorubicin—hematologic cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Anaemia—Prednisone—hematologic cancer	0.000327	0.000327	CcSEcCtD
Oritavancin—Headache—Carmustine—hematologic cancer	0.000326	0.000326	CcSEcCtD
Oritavancin—Rash—Alitretinoin—hematologic cancer	0.000325	0.000325	CcSEcCtD
Oritavancin—Nervous system disorder—Dexamethasone—hematologic cancer	0.000325	0.000325	CcSEcCtD
Oritavancin—Nervous system disorder—Betamethasone—hematologic cancer	0.000325	0.000325	CcSEcCtD
Oritavancin—Dermatitis—Alitretinoin—hematologic cancer	0.000325	0.000325	CcSEcCtD
Oritavancin—Vomiting—Ifosfamide—hematologic cancer	0.000324	0.000324	CcSEcCtD
Oritavancin—Hypersensitivity—Cisplatin—hematologic cancer	0.000324	0.000324	CcSEcCtD
Oritavancin—Tachycardia—Dexamethasone—hematologic cancer	0.000323	0.000323	CcSEcCtD
Oritavancin—Tachycardia—Betamethasone—hematologic cancer	0.000323	0.000323	CcSEcCtD
Oritavancin—Headache—Alitretinoin—hematologic cancer	0.000323	0.000323	CcSEcCtD
Oritavancin—Angioedema—Prednisone—hematologic cancer	0.000323	0.000323	CcSEcCtD
Oritavancin—Diarrhoea—Gemcitabine—hematologic cancer	0.000323	0.000323	CcSEcCtD
Oritavancin—Nausea—Thalidomide—hematologic cancer	0.000322	0.000322	CcSEcCtD
Oritavancin—Rash—Ifosfamide—hematologic cancer	0.000322	0.000322	CcSEcCtD
Oritavancin—Dermatitis—Ifosfamide—hematologic cancer	0.000321	0.000321	CcSEcCtD
Oritavancin—Erythema multiforme—Methotrexate—hematologic cancer	0.000321	0.000321	CcSEcCtD
Oritavancin—Dizziness—Irinotecan—hematologic cancer	0.00032	0.00032	CcSEcCtD
Oritavancin—Urticaria—Etoposide—hematologic cancer	0.00032	0.00032	CcSEcCtD
Oritavancin—Vomiting—Vincristine—hematologic cancer	0.000316	0.000316	CcSEcCtD
Oritavancin—Urticaria—Prednisolone—hematologic cancer	0.000316	0.000316	CcSEcCtD
Oritavancin—Cardiac disorder—Methotrexate—hematologic cancer	0.000315	0.000315	CcSEcCtD
Oritavancin—Rash—Vincristine—hematologic cancer	0.000313	0.000313	CcSEcCtD
Oritavancin—Dermatitis—Vincristine—hematologic cancer	0.000313	0.000313	CcSEcCtD
Oritavancin—Oedema peripheral—Epirubicin—hematologic cancer	0.000313	0.000313	CcSEcCtD
Oritavancin—Connective tissue disorder—Epirubicin—hematologic cancer	0.000312	0.000312	CcSEcCtD
Oritavancin—Headache—Vincristine—hematologic cancer	0.000311	0.000311	CcSEcCtD
Oritavancin—Nausea—Carmustine—hematologic cancer	0.000309	0.000309	CcSEcCtD
Oritavancin—Vomiting—Mitoxantrone—hematologic cancer	0.000308	0.000308	CcSEcCtD
Oritavancin—Vomiting—Irinotecan—hematologic cancer	0.000308	0.000308	CcSEcCtD
Oritavancin—Immune system disorder—Methotrexate—hematologic cancer	0.000307	0.000307	CcSEcCtD
Oritavancin—Nausea—Alitretinoin—hematologic cancer	0.000306	0.000306	CcSEcCtD
Oritavancin—Mediastinal disorder—Methotrexate—hematologic cancer	0.000306	0.000306	CcSEcCtD
Oritavancin—Rash—Mitoxantrone—hematologic cancer	0.000305	0.000305	CcSEcCtD
Oritavancin—Rash—Irinotecan—hematologic cancer	0.000305	0.000305	CcSEcCtD
Oritavancin—Dermatitis—Irinotecan—hematologic cancer	0.000305	0.000305	CcSEcCtD
Oritavancin—Dermatitis—Mitoxantrone—hematologic cancer	0.000305	0.000305	CcSEcCtD
Oritavancin—Headache—Irinotecan—hematologic cancer	0.000303	0.000303	CcSEcCtD
Oritavancin—Headache—Mitoxantrone—hematologic cancer	0.000303	0.000303	CcSEcCtD
Oritavancin—Nausea—Ifosfamide—hematologic cancer	0.000303	0.000303	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000302	0.000302	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000302	0.000302	CcSEcCtD
Oritavancin—Myalgia—Prednisone—hematologic cancer	0.000301	0.000301	CcSEcCtD
Oritavancin—Diarrhoea—Cisplatin—hematologic cancer	0.000301	0.000301	CcSEcCtD
Oritavancin—Erythema multiforme—Epirubicin—hematologic cancer	0.0003	0.0003	CcSEcCtD
Oritavancin—Vomiting—Gemcitabine—hematologic cancer	0.0003	0.0003	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000299	0.000299	CcSEcCtD
Oritavancin—Rash—Gemcitabine—hematologic cancer	0.000297	0.000297	CcSEcCtD
Oritavancin—Dermatitis—Gemcitabine—hematologic cancer	0.000297	0.000297	CcSEcCtD
Oritavancin—Hypersensitivity—Etoposide—hematologic cancer	0.000297	0.000297	CcSEcCtD
Oritavancin—Malnutrition—Methotrexate—hematologic cancer	0.000296	0.000296	CcSEcCtD
Oritavancin—Headache—Gemcitabine—hematologic cancer	0.000295	0.000295	CcSEcCtD
Oritavancin—Nausea—Vincristine—hematologic cancer	0.000295	0.000295	CcSEcCtD
Oritavancin—Cardiac disorder—Epirubicin—hematologic cancer	0.000295	0.000295	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisolone—hematologic cancer	0.000293	0.000293	CcSEcCtD
Oritavancin—Urticaria—Triamcinolone—hematologic cancer	0.00029	0.00029	CcSEcCtD
Oritavancin—Oedema peripheral—Doxorubicin—hematologic cancer	0.00029	0.00029	CcSEcCtD
Oritavancin—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000289	0.000289	CcSEcCtD
Oritavancin—Nausea—Irinotecan—hematologic cancer	0.000288	0.000288	CcSEcCtD
Oritavancin—Nausea—Mitoxantrone—hematologic cancer	0.000288	0.000288	CcSEcCtD
Oritavancin—Immune system disorder—Epirubicin—hematologic cancer	0.000287	0.000287	CcSEcCtD
Oritavancin—Infection—Prednisone—hematologic cancer	0.000287	0.000287	CcSEcCtD
Oritavancin—Mediastinal disorder—Epirubicin—hematologic cancer	0.000286	0.000286	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000286	0.000286	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000286	0.000286	CcSEcCtD
Oritavancin—Pruritus—Etoposide—hematologic cancer	0.000285	0.000285	CcSEcCtD
Oritavancin—Nervous system disorder—Prednisone—hematologic cancer	0.000283	0.000283	CcSEcCtD
Oritavancin—Tachycardia—Prednisone—hematologic cancer	0.000282	0.000282	CcSEcCtD
Oritavancin—Skin disorder—Prednisone—hematologic cancer	0.00028	0.00028	CcSEcCtD
Oritavancin—Nausea—Gemcitabine—hematologic cancer	0.00028	0.00028	CcSEcCtD
Oritavancin—Vomiting—Cisplatin—hematologic cancer	0.00028	0.00028	CcSEcCtD
Oritavancin—Erythema multiforme—Doxorubicin—hematologic cancer	0.000278	0.000278	CcSEcCtD
Oritavancin—Rash—Cisplatin—hematologic cancer	0.000277	0.000277	CcSEcCtD
Oritavancin—Dermatitis—Cisplatin—hematologic cancer	0.000277	0.000277	CcSEcCtD
Oritavancin—Malnutrition—Epirubicin—hematologic cancer	0.000277	0.000277	CcSEcCtD
Oritavancin—Diarrhoea—Etoposide—hematologic cancer	0.000276	0.000276	CcSEcCtD
Oritavancin—Anaemia—Methotrexate—hematologic cancer	0.000273	0.000273	CcSEcCtD
Oritavancin—Cardiac disorder—Doxorubicin—hematologic cancer	0.000273	0.000273	CcSEcCtD
Oritavancin—Hypersensitivity—Triamcinolone—hematologic cancer	0.000269	0.000269	CcSEcCtD
Oritavancin—Dizziness—Etoposide—hematologic cancer	0.000266	0.000266	CcSEcCtD
Oritavancin—Immune system disorder—Doxorubicin—hematologic cancer	0.000266	0.000266	CcSEcCtD
Oritavancin—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000265	0.000265	CcSEcCtD
Oritavancin—Urticaria—Dexamethasone—hematologic cancer	0.000263	0.000263	CcSEcCtD
Oritavancin—Urticaria—Betamethasone—hematologic cancer	0.000263	0.000263	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000263	0.000263	CcSEcCtD
Oritavancin—Dizziness—Prednisolone—hematologic cancer	0.000263	0.000263	CcSEcCtD
Oritavancin—Nausea—Cisplatin—hematologic cancer	0.000261	0.000261	CcSEcCtD
Oritavancin—Pruritus—Triamcinolone—hematologic cancer	0.000258	0.000258	CcSEcCtD
Oritavancin—Vomiting—Etoposide—hematologic cancer	0.000256	0.000256	CcSEcCtD
Oritavancin—Malnutrition—Doxorubicin—hematologic cancer	0.000256	0.000256	CcSEcCtD
Oritavancin—Anaemia—Epirubicin—hematologic cancer	0.000256	0.000256	CcSEcCtD
Oritavancin—Rash—Etoposide—hematologic cancer	0.000254	0.000254	CcSEcCtD
Oritavancin—Dermatitis—Etoposide—hematologic cancer	0.000254	0.000254	CcSEcCtD
Oritavancin—Headache—Etoposide—hematologic cancer	0.000252	0.000252	CcSEcCtD
Oritavancin—Myalgia—Methotrexate—hematologic cancer	0.000252	0.000252	CcSEcCtD
Oritavancin—Rash—Prednisolone—hematologic cancer	0.00025	0.00025	CcSEcCtD
Oritavancin—Dermatitis—Prednisolone—hematologic cancer	0.00025	0.00025	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.00025	0.00025	CcSEcCtD
Oritavancin—Headache—Prednisolone—hematologic cancer	0.000249	0.000249	CcSEcCtD
Oritavancin—Dizziness—Triamcinolone—hematologic cancer	0.000242	0.000242	CcSEcCtD
Oritavancin—Infection—Methotrexate—hematologic cancer	0.00024	0.00024	CcSEcCtD
Oritavancin—Nausea—Etoposide—hematologic cancer	0.000239	0.000239	CcSEcCtD
Oritavancin—Nervous system disorder—Methotrexate—hematologic cancer	0.000237	0.000237	CcSEcCtD
Oritavancin—Anaemia—Doxorubicin—hematologic cancer	0.000237	0.000237	CcSEcCtD
Oritavancin—Nausea—Prednisolone—hematologic cancer	0.000236	0.000236	CcSEcCtD
Oritavancin—Myalgia—Epirubicin—hematologic cancer	0.000235	0.000235	CcSEcCtD
Oritavancin—Pruritus—Dexamethasone—hematologic cancer	0.000234	0.000234	CcSEcCtD
Oritavancin—Pruritus—Betamethasone—hematologic cancer	0.000234	0.000234	CcSEcCtD
Oritavancin—Skin disorder—Methotrexate—hematologic cancer	0.000234	0.000234	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000234	0.000234	CcSEcCtD
Oritavancin—Vomiting—Triamcinolone—hematologic cancer	0.000232	0.000232	CcSEcCtD
Oritavancin—Rash—Triamcinolone—hematologic cancer	0.00023	0.00023	CcSEcCtD
Oritavancin—Dermatitis—Triamcinolone—hematologic cancer	0.00023	0.00023	CcSEcCtD
Oritavancin—Urticaria—Prednisone—hematologic cancer	0.000229	0.000229	CcSEcCtD
Oritavancin—Headache—Triamcinolone—hematologic cancer	0.000229	0.000229	CcSEcCtD
Oritavancin—Diarrhoea—Betamethasone—hematologic cancer	0.000227	0.000227	CcSEcCtD
Oritavancin—Diarrhoea—Dexamethasone—hematologic cancer	0.000227	0.000227	CcSEcCtD
Oritavancin—Infection—Epirubicin—hematologic cancer	0.000224	0.000224	CcSEcCtD
Oritavancin—Nervous system disorder—Epirubicin—hematologic cancer	0.000221	0.000221	CcSEcCtD
Oritavancin—Tachycardia—Epirubicin—hematologic cancer	0.00022	0.00022	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.00022	0.00022	CcSEcCtD
Oritavancin—Skin disorder—Epirubicin—hematologic cancer	0.000219	0.000219	CcSEcCtD
Oritavancin—Dizziness—Betamethasone—hematologic cancer	0.000219	0.000219	CcSEcCtD
Oritavancin—Dizziness—Dexamethasone—hematologic cancer	0.000219	0.000219	CcSEcCtD
Oritavancin—Myalgia—Doxorubicin—hematologic cancer	0.000218	0.000218	CcSEcCtD
Oritavancin—Nausea—Triamcinolone—hematologic cancer	0.000217	0.000217	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000216	0.000216	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisone—hematologic cancer	0.000213	0.000213	CcSEcCtD
Oritavancin—Vomiting—Dexamethasone—hematologic cancer	0.000211	0.000211	CcSEcCtD
Oritavancin—Vomiting—Betamethasone—hematologic cancer	0.000211	0.000211	CcSEcCtD
Oritavancin—Rash—Dexamethasone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Oritavancin—Rash—Betamethasone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Oritavancin—Dermatitis—Dexamethasone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Oritavancin—Dermatitis—Betamethasone—hematologic cancer	0.000209	0.000209	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000208	0.000208	CcSEcCtD
Oritavancin—Headache—Betamethasone—hematologic cancer	0.000208	0.000208	CcSEcCtD
Oritavancin—Headache—Dexamethasone—hematologic cancer	0.000208	0.000208	CcSEcCtD
Oritavancin—Infection—Doxorubicin—hematologic cancer	0.000208	0.000208	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000206	0.000206	CcSEcCtD
Oritavancin—Nervous system disorder—Doxorubicin—hematologic cancer	0.000205	0.000205	CcSEcCtD
Oritavancin—Pruritus—Prednisone—hematologic cancer	0.000204	0.000204	CcSEcCtD
Oritavancin—Tachycardia—Doxorubicin—hematologic cancer	0.000204	0.000204	CcSEcCtD
Oritavancin—Skin disorder—Doxorubicin—hematologic cancer	0.000203	0.000203	CcSEcCtD
Oritavancin—Diarrhoea—Prednisone—hematologic cancer	0.000197	0.000197	CcSEcCtD
Oritavancin—Nausea—Betamethasone—hematologic cancer	0.000197	0.000197	CcSEcCtD
Oritavancin—Nausea—Dexamethasone—hematologic cancer	0.000197	0.000197	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000195	0.000195	CcSEcCtD
Oritavancin—Urticaria—Methotrexate—hematologic cancer	0.000192	0.000192	CcSEcCtD
Oritavancin—Dizziness—Prednisone—hematologic cancer	0.000191	0.000191	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.00019	0.00019	CcSEcCtD
Oritavancin—Vomiting—Prednisone—hematologic cancer	0.000184	0.000184	CcSEcCtD
Oritavancin—Rash—Prednisone—hematologic cancer	0.000182	0.000182	CcSEcCtD
Oritavancin—Dermatitis—Prednisone—hematologic cancer	0.000182	0.000182	CcSEcCtD
Oritavancin—Headache—Prednisone—hematologic cancer	0.000181	0.000181	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.00018	0.00018	CcSEcCtD
Oritavancin—Urticaria—Epirubicin—hematologic cancer	0.000179	0.000179	CcSEcCtD
Oritavancin—Hypersensitivity—Methotrexate—hematologic cancer	0.000178	0.000178	CcSEcCtD
Oritavancin—Nausea—Prednisone—hematologic cancer	0.000171	0.000171	CcSEcCtD
Oritavancin—Pruritus—Methotrexate—hematologic cancer	0.000171	0.000171	CcSEcCtD
Oritavancin—Hypersensitivity—Epirubicin—hematologic cancer	0.000166	0.000166	CcSEcCtD
Oritavancin—Urticaria—Doxorubicin—hematologic cancer	0.000166	0.000166	CcSEcCtD
Oritavancin—Diarrhoea—Methotrexate—hematologic cancer	0.000165	0.000165	CcSEcCtD
Oritavancin—Pruritus—Epirubicin—hematologic cancer	0.00016	0.00016	CcSEcCtD
Oritavancin—Dizziness—Methotrexate—hematologic cancer	0.00016	0.00016	CcSEcCtD
Oritavancin—Diarrhoea—Epirubicin—hematologic cancer	0.000154	0.000154	CcSEcCtD
Oritavancin—Hypersensitivity—Doxorubicin—hematologic cancer	0.000154	0.000154	CcSEcCtD
Oritavancin—Vomiting—Methotrexate—hematologic cancer	0.000153	0.000153	CcSEcCtD
Oritavancin—Rash—Methotrexate—hematologic cancer	0.000152	0.000152	CcSEcCtD
Oritavancin—Dermatitis—Methotrexate—hematologic cancer	0.000152	0.000152	CcSEcCtD
Oritavancin—Headache—Methotrexate—hematologic cancer	0.000151	0.000151	CcSEcCtD
Oritavancin—Dizziness—Epirubicin—hematologic cancer	0.000149	0.000149	CcSEcCtD
Oritavancin—Pruritus—Doxorubicin—hematologic cancer	0.000148	0.000148	CcSEcCtD
Oritavancin—Vomiting—Epirubicin—hematologic cancer	0.000144	0.000144	CcSEcCtD
Oritavancin—Nausea—Methotrexate—hematologic cancer	0.000143	0.000143	CcSEcCtD
Oritavancin—Diarrhoea—Doxorubicin—hematologic cancer	0.000143	0.000143	CcSEcCtD
Oritavancin—Rash—Epirubicin—hematologic cancer	0.000142	0.000142	CcSEcCtD
Oritavancin—Dermatitis—Epirubicin—hematologic cancer	0.000142	0.000142	CcSEcCtD
Oritavancin—Headache—Epirubicin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Oritavancin—Dizziness—Doxorubicin—hematologic cancer	0.000138	0.000138	CcSEcCtD
Oritavancin—Nausea—Epirubicin—hematologic cancer	0.000134	0.000134	CcSEcCtD
Oritavancin—Vomiting—Doxorubicin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Oritavancin—Rash—Doxorubicin—hematologic cancer	0.000132	0.000132	CcSEcCtD
Oritavancin—Dermatitis—Doxorubicin—hematologic cancer	0.000132	0.000132	CcSEcCtD
Oritavancin—Headache—Doxorubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Oritavancin—Nausea—Doxorubicin—hematologic cancer	0.000124	0.000124	CcSEcCtD
